GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $411,000 | +33.0% | 9,971 | +15.2% | 0.03% | +20.0% |
| Q1 2021 | $309,000 | 0.0% | 8,652 | +3.2% | 0.02% | -3.8% |
| Q4 2020 | $309,000 | -23.9% | 8,385 | -22.2% | 0.03% | -31.6% |
| Q3 2020 | $406,000 | -19.9% | 10,775 | -13.3% | 0.04% | -25.5% |
| Q2 2020 | $507,000 | +11.7% | 12,428 | +3.8% | 0.05% | -8.9% |
| Q1 2020 | $454,000 | +47.4% | 11,977 | +82.9% | 0.06% | +86.7% |
| Q4 2019 | $308,000 | +21.3% | 6,547 | +10.1% | 0.03% | +7.1% |
| Q3 2019 | $254,000 | +7.2% | 5,945 | +0.3% | 0.03% | +12.0% |
| Q2 2019 | $237,000 | +0.9% | 5,930 | +5.5% | 0.02% | 0.0% |
| Q1 2019 | $235,000 | +8.8% | 5,622 | +4.7% | 0.02% | +4.2% |
| Q3 2018 | $216,000 | -3.6% | 5,368 | -3.5% | 0.02% | +9.1% |
| Q2 2018 | $224,000 | +9.8% | 5,561 | +6.3% | 0.02% | -4.3% |
| Q1 2018 | $204,000 | – | 5,231 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |